Eszopiclone is a nonbenzodiazepine active pharmaceutical ingredient used in medications for the short-term and long-term management of insomnia. It is one of the few FDA-regulated hypnotic compounds without prescribed limits on treatment duration, with evidence supporting benefits for up to six months and potential efficacy beyond one year.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 138729-47-2
Pantoprazole sodium
pharmaceutical raw material
Ibandronate sodium
pharmaceutical raw material
Brinzolamide
pharmaceutical raw material
(2S,3S,4S,5R,6S)-6-[3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
pharmaceutical raw material
(+/-)-Zopiclone-d3 (N-methyl-d3)
research compound
Zopiclone
pharmaceutical raw material
[(7S)-6-(5-chloro-2-pyridinyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
GBBSUAFBMRNDJC-INIZCTEOSA-N
CN1CCN(CC1)C(=O)O[C@H]2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl